Fifth Third Bancorp
IRMD icon

Fifth Third Bancorp’s iRadimed IRMD Stock Holding History

Fifth Third Bancorp’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Buy
2,233
+181
+9% +$16.5K ﹤0.01% 2565
2026
Q1 		$198K Buy
+2,052
New +$205K ﹤0.01% 2552
2023
Q4 		– Sell
-283
Closed -$12.6K – 2581
2023
Q3 		$12.6K Hold
283
– – ﹤0.01% 1889
2023
Q2 		$13.5K Hold
283
– – ﹤0.01% 1885
2023
Q1 		$11.1K Hold
283
– – ﹤0.01% 2055
2022
Q4 		$8.01K Hold
283
– – ﹤0.01% 2045
2022
Q3 		$9K Hold
283
– – ﹤0.01% 1987
2022
Q2 		$10K Hold
283
– – ﹤0.01% 1996
2022
Q1 		$13K Hold
283
– – ﹤0.01% 1957
2021
Q4 		$13K Hold
283
– – ﹤0.01% 2000
2021
Q3 		$10K Buy
+283
New +$9.62K ﹤0.01% 2005

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fifth Third Bancorp's IRMD Position: Q2 2026 in Review

Fifth Third Bancorp increased its iRadimed (IRMD) stake by 8.8% in Q2 2026, buying an estimated $16.5K and bringing the position to 2,233 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #2565.

Fifth Third Bancorp first reported a position in IRMD in Q3 2021 and has held it in 11 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Fifth Third Bancorp held 2,233 shares of iRadimed worth $213K as of Q2 2026.
  • Fifth Third Bancorp bought 181 iRadimed shares in Q2 2026, an estimated $16.5K.
  • iRadimed made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2565 holding.
  • Fifth Third Bancorp first reported a position in iRadimed in Q3 2021 and has held it in 11 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.